Rehovot, Israel
December 2, 2008
Evogene Ltd. (TASE: EVGN) today announced strengthening its
on-going collaboration with
Bayer CropScience
to increase yield in rice. In June 2007, the two companies
announced a collaboration to increase rice productivity and
yield. Pursuant to the collaboration agreement between the
companies, Bayer CropScience has recently exercised its option
to exclusive licensing rights in rice to additional candidate
genes discovered by Evogene.
The candidate genes, which were predicted by Evogene’s
computational technology (the "ATHLETE") to improve yield,
displayed yield improvement when validated by Evogene in model
plants, and will be evaluated by Bayer CropScience in rice.
Evogene is a world leading developer of improved plant
traits. The company’s proprietary product development platform
combines state of the art computational gene discovery
technology (The 'ATHLETE'), plant and field validation
capabilities and unique selection systems. Evogene's current
programs focus on the improvement of key plant traits, such as
yield and stress tolerance, and the improvement of plants
specifically for biofuel uses. Evogene has collaboration and
licensing agreements with world leading companies in the
agro-biotech and alternative energy industries. Evogene's
headquarters are in Rehovot, Israel, and its stock is traded on
the Tel Aviv Stock Exchange (TASE:EVGN).
More news
from Bayer
CropScience |
|
